New 2,5-diaryl tetrahydrofurans and analogs thereof as paf antagonists
申请人:Merck & Co., Inc.
公开号:EP0322033A2
公开(公告)日:1989-06-28
A class of 2,5-diaryl tetrahydrofuran derivatives are PAF antagonists and are therefore useful in the treatment of various diseases including prevention of platelet aggregation, hypotension, inflammation, asthma, lung edema, adult respiratory distress syndrome, various shock syndromes, cardiovascular disorders and other related skeletal-muscular disorders.